According to Lazard Capital Markets’ latest report from its Equity Research Department, “What’s Next: It’s Private,” Truveris is one of 2013’s most disruptive private companies in Managed Care and Healthcare IT. The report is based on analysis of products or services currently “offered by private companies in the industries they cover,” taking into account the implications within their respective competitive landscapes. These companies or products are considered “disruptive” if they have the potential to evoke change within their industries, or have found a new way to produce excellent results.

Here is what Lazard has to say about Truveris:

Product: Real-time pharmacy benefit claim adjudication platform and pharmacy benefit management (PBM) bid pricing platform.

Truveris is a health information technology company delivering pharmacy data validation, analytics, and pricing solutions through a SaaS platform. The company’s clients include WellPoint, AutoZone, Neiman Marcus, Morgan Stanley and AXA Equitable.

We believe Truveris offers disruptive technology by enabling payers of prescription benefits, such as large corporations and pension plans, to review the accuracy of all of the claims on their PBM invoice prior to payment. The company’s claim adjudication platform provides pharmacy bill review services to clients prior to paying PBMs. The bid pricing platform can replicate each bid’s performance with a plan’s actual claims data as well as drug spend projections. An objective scorecard is also provided to rank RFP results.

Truveris’ services are disruptive since they have the potential to reveal tens of millions of dollars in overcharges and erroneous PBM claims.

During its first year of business, Truveris validated nearly 250,000 prescription claims. In its second year, that number grew to 10 million claims. In 2012, Truveris analyzed more than 300 million claims, and it’s continuing that disruptive momentum in 2013. If your company is interested in becoming more disruptive this year, visit the Truveris web site to learn more about our product suite and services: www.truveris.com. Please also feel free to follow Truveris for updates on Facebook, LinkedIn and Twitter.